KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Astrazeneca (AZN) over the last 15 years, with Q4 2025 value amounting to -$3.0 million.

  • Astrazeneca's Dividends Paid - Common changed 0.0% to -$3.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.0 billion, marking a year-over-year decrease of 738.82%. This contributed to the annual value of -$5.0 billion for FY2025, which is 738.82% down from last year.
  • Latest data reveals that Astrazeneca reported Dividends Paid - Common of -$3.0 million as of Q4 2025, which was down 0.0% from -$1.6 billion recorded in Q3 2025.
  • Astrazeneca's 5-year Dividends Paid - Common high stood at $7.7 billion for Q4 2021, and its period low was -$3.3 billion during Q1 2025.
  • Moreover, its 5-year median value for Dividends Paid - Common was -$1.5 billion (2021), whereas its average is -$841.7 million.
  • In the last 5 years, Astrazeneca's Dividends Paid - Common crashed by 2033.21% in 2022 and then surged by 4117.65% in 2025.
  • Over the past 5 years, Astrazeneca's Dividends Paid - Common (Quarter) stood at $7.7 billion in 2021, then plummeted by 138.52% to -$3.0 billion in 2022, then soared by 99.26% to -$22.0 million in 2023, then soared by 86.36% to -$3.0 million in 2024, then changed by 0.0% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q4 2025, -$1.6 billion for Q3 2025, and -$10.0 million during Q2 2025.